Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-117543
Filing Date
2016-08-09
Accepted
2016-08-09 11:59:29
Documents
44
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v445267_10q.htm 10-Q 289208
2 EXHIBIT 31.1 v445267_ex31-1.htm EX-31.1 9898
3 EXHIBIT 32.1 v445267_ex32-1.htm EX-32.1 4637
  Complete submission text file 0001144204-16-117543.txt   2332230

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT ttnp-20160630.xml EX-101.INS 481229
5 XBRL TAXONOMY EXTENSION SCHEMA ttnp-20160630.xsd EX-101.SCH 25009
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ttnp-20160630_cal.xml EX-101.CAL 24277
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ttnp-20160630_def.xml EX-101.DEF 146117
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttnp-20160630_lab.xml EX-101.LAB 194981
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttnp-20160630_pre.xml EX-101.PRE 171796
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-13341 | Film No.: 161816948
SIC: 2836 Biological Products, (No Diagnostic Substances)